Key result
US mortality for concurrent CAD and dyslipidemia rises ~206% over two decades.
Why the study?
Trends and disparities in USA mortality rates associated with the co-occurrence of coronary artery disease and dyslipidemia from 1999 to 2020 were not well defined.
Population
613,969 CAD and dyslipidemia-related deaths in USA adults aged 25 and older
Design
Retrospective database study using CDC WONDER multiple cause of death files
Authors
Loading...
Rising concurrent CAD-dyslipidemia mortality warrants renewed prevention vigilance; leaves open causal drivers and targeted intervention effects.
Observational (n=613,969)
Absolute Event Rate: 19% vs 6.2%
Mortality due to concurrent CAD and dyslipidemia in the USA has significantly increased from 1999 to 2020, with higher rates in men, non-Hispanic American Indian and white populations, and nonmetropolitan areas.
Cheema et al. (2025) conducted an observational in Coronary artery disease and dyslipidemia (n=613,969). Age-adjusted mortality rates for concurrent coronary artery disease and dyslipidemia in the USA increased from 6.2 per 100,000 in 1999 to 19.0 per 100,000 in 2020.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: